title: Medicine. What are the right targets for psychopharmacology?
authors.affiliation: Harvard University, Boston, MA 02138, USA.
authors.forename: Steven E
authors.initials: SE
authors.lastname: Hyman
authors.forename: Wayne S
authors.initials: WS
authors.lastname: Fenton
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D003071:Cognition / Q000187:drug effects; D003072:Cognition Disorders / Q000188:drug therapy / Q000209:etiology; D015975:Consensus Development Conferences, NIH as Topic; D006801:Humans; D001523:Mental Disorders / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D009315:National Institute of Mental Health (U.S.); D011600:Psychopharmacology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012559:Schizophrenia / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D012565:Schizophrenic Psychology; D014481:United States
chemical_list: D011619:Psychotropic Drugs